| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 436,1 k € | -6.0% | 464,0 k € | +8.0% | 429,5 k € | -7.5% | 464,3 k € | +5.5% | 440,3 k € | +55.2% | 283,6 k € | -7.2% | 305,6 k € | +13.3% | 269,8 k € | -34.4% | 411,3 k € | -2.5% | 421,9 k € | +2.8% | 410,5 k € | +18.1% | 347,5 k € | |
| EBITDA | 231,8 k € | -14.0% | 269,4 k € | +4.5% | 257,9 k € | -16.0% | 306,9 k € | +5.8% | 290,0 k € | +90.2% | 152,4 k € | -14.4% | 178,0 k € | +30.6% | 136,3 k € | -50.7% | 276,5 k € | +1.8% | 271,5 k € | +5.2% | 258,1 k € | +25.4% | 205,7 k € | |
| Operating profit | 220,2 k € | -12.2% | 250,7 k € | +13.0% | 221,8 k € | -16.1% | 264,4 k € | +6.4% | 248,4 k € | +145.7% | 101,1 k € | -20.5% | 127,2 k € | +53.2% | 83,0 k € | -63.1% | 225,1 k € | +5.2% | 214,0 k € | +10.0% | 194,5 k € | +93.4% | 100,6 k € | |
| Profit/loss | 157,8 k € | -17.5% | 191,4 k € | +29.2% | 148,1 k € | -21.3% | 188,1 k € | -5.0% | 198,0 k € | +286.5% | 51,2 k € | -26.7% | 69,9 k € | +104.0% | 34,3 k € | +91.4% | 17,9 k € | -84.4% | 114,9 k € | +17.1% | 98,1 k € | +90.5% | 51,5 k € | |
| Equity | 506,5 k € | +45.2% | 348,7 k € | +121.6% | 157,4 k € | +13.0% | 139,3 k € | -52.2% | 291,2 k € | -15.1% | 343,2 k € | +17.5% | 292,0 k € | -49.0% | 572,1 k € | +6.4% | 537,8 k € | +3.4% | 519,9 k € | +28.4% | 405,0 k € | +32.0% | 306,9 k € | |
| Total assets | 906,3 k € | +24.6% | 727,3 k € | +12.5% | 646,6 k € | -35.7% | 1,0 M € | -7.3% | 1,1 M € | -3.0% | 1,1 M € | -6.3% | 1,2 M € | -27.9% | 1,7 M € | -9.1% | 1,8 M € | -4.1% | 1,9 M € | -0.4% | 1,9 M € | -5.7% | 2,0 M € | |
| Cash | 436,5 k € | +33.0% | 328,2 k € | +22.6% | 267,6 k € | +12.8% | 237,3 k € | -33.9% | 359,3 k € | +74.0% | 206,4 k € | +29.7% | 159,2 k € | +51.2% | 105,3 k € | -66.4% | 313,2 k € | +26.3% | 247,9 k € | +4.2% | 237,9 k € | -41.0% | 403,0 k € | |
| Debts | 399,8 k € | +5.6% | 378,6 k € | -22.6% | 489,2 k € | -43.5% | 866,0 k € | +9.2% | 793,0 k € | +2.5% | 773,6 k € | -14.1% | 900,3 k € | -16.7% | 1,1 M € | -15.6% | 1,3 M € | -6.5% | 1,4 M € | -8.2% | 1,5 M € | -12.9% | 1,7 M € | |
| Staff | 3,1 | 2,9 | 4,9 | 2,5 | 2,5 | 2,4 | 2,5 | 2,5 | 2,5 | 2,8 | 2,6 | 2,6 | ||||||||||||
Private limited company · Seneffe · incorporated on 25/06/2012 · 3,1 ETP
Private limited company profitable and well capitalised. Cash position rising (+33.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMACIE DE LA GRAND RUE is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Seneffe. It employs on average 3,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette